Indraprastha Medical Corporation Ltd vs Modern Diagnostic Research Centre Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 299.95 as of 23 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 215 on March 2021 to 18.5 on March 2026 . This represents a CAGR of -33.56% over 6 yearsThe P/E Ratio of Modern Diagnostic & Research Centre Ltd changed from 15.4 on March 2026 to 15.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 492.74 crore on March 2021 to ₹ 3407 crore on March 2026 . This represents a CAGR of 38.03% over 6 yearsThe Market Cap of Modern Diagnostic & Research Centre Ltd changed from ₹ 80.96 crore on March 2026 to ₹ 80.96 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 414.57 crore as compare to the Mar '26 revenue of ₹ 372.14 crore. This represent the growth of 11.4% The revenue of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Indraprastha Medical Corporation Ltd for the Jun '26 is ₹ 88.23 crore as compare to the Mar '26 ebitda of ₹ 67.84 crore. This represent the growth of 30.06% The ebitda of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 55.85 crore over 9 quarters. This represents a CAGR of 10.33% The net profit of Modern Diagnostic & Research Centre Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Modern Diagnostic & Research Centre Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About Modern Diagnostic & Research Centre Ltd

The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992.
Modern Diagnostic & Research Centre Limited was erstwhile incorporated as 'Modern Diagnostic & Research Centre Private Limited' as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi . Thereafter, the Company acquired the business of M/s.
Modern Diagnostics & Research Centre, a Proprietorship Concern through Business Transfer Agreement in 2013.
Subsequently, its status got converted from private limited into public limited and the name of the Company was changed to 'Modern Diagnostic & Research Centre Limited' pursuant to fresh certificate of incorporation dated December 18, 2024 issued by Registrar of Companies, Central Processing Centre.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Modern Diagnostic & Research Centre Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr while Market cap of Modern Diagnostic & Research Centre Ltd is 90 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd?

As of October 25, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹299.95. On the other hand, Modern Diagnostic & Research Centre Ltd stock price is INR ₹60.0.

How do dividend payouts of Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Modern Diagnostic & Research Centre Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.